Long Term Effect of Somatropin in Subjects With Intrauterine Growth Retardation

PHASE4CompletedINTERVENTIONAL
Enrollment

57

Participants

Timeline

Start Date

April 30, 2000

Primary Completion Date

April 30, 2003

Study Completion Date

April 30, 2003

Conditions
Foetal Growth ProblemSmall for Gestational Age
Interventions
DRUG

somatropin

1.2 IU/kg/week, one injection per day, in six days out of seven days, for 12 months

DRUG

somatropin

1.2 IU/kg/week, one injection per day, in six days out of seven days, for 6 months out of 12 months (i.e. alternating periods of 6 months of treatment and non-treatment, respectively)

DRUG

somatropin

2.4 IU/kg/week, one injection per day, in six days out of seven days, for 6 months out of 12 months (i.e. alternating periods of 6 months of treatment and non-treatment, respectively)

Trial Locations (1)

Unknown

Novo Nordisk Investigational Site, Paris

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Novo Nordisk A/S

INDUSTRY

NCT01734447 - Long Term Effect of Somatropin in Subjects With Intrauterine Growth Retardation | Biotech Hunter | Biotech Hunter